Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
287
-
Total 13F shares, excl. options
-
52.1M
-
Shares change
-
-1.27M
-
Total reported value, excl. options
-
$5.68B
-
Value change
-
-$159M
-
Put/Call ratio
-
1.69
-
Number of buys
-
128
-
Number of sells
-
-185
-
Price
-
$109.03
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2016
389 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q4 2016.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 287 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.1M shares
.
Largest 10 shareholders include PUTNAM INVESTMENTS LLC (7.67M shares), FMR LLC (7.47M shares), VANGUARD GROUP INC (4.37M shares), RENAISSANCE TECHNOLOGIES LLC (1.56M shares), CADIAN CAPITAL MANAGEMENT, LP (1.54M shares), Bank of New York Mellon Corp (1.4M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.26M shares), FIL Ltd (1.22M shares), BlackRock Fund Advisors (1.13M shares), and BlackRock Institutional Trust Company, N.A. (1.09M shares).
This table shows the top 287 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.